Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands. 2013

Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
Radioisotope Research Group, Nuclear Science Research School, NSTRI, Tehran, Iran. m.sadeghzadeh@ut.ac.ir

This study presents the synthesis and biological evaluation of a new series of arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as sigma receptor ligands. It was found that a number of halogen substituted sulfonamides display relatively high and low affinities to σ1 and σ2 receptors, respectively. The σ1 affinities and subtype selectivities of four piperidine derivatives were also found to be generally comparable to those of piperazine analogues. Compared to σ1-Rs compounds with n = 0 and 2, those with n = 1 proved to have optimal length of carbon chain by exhibiting higher affinities. Within this series, the 4-benzyl-1-(3-iodobenzylsulfonyl)piperidine sigma ligand was identified with 96-fold σ1/σ2 selectivity ratio (Kiσ1 = 0.96 ± 0.05 nM and Kiσ2 = 91.8 ± 8.1 nM).

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010880 Piperidines A family of hexahydropyridines.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000077489 Piperazine An anti-nematodal agent effective against the intestinal nematodes ASCARIS LUMBRICOIDES (roundworm) and ENTEROBIUS VERMICULARIS (pinworm, threadworm). It produces a neuromuscular block leading to flaccid muscle paralysis in susceptible worms, which are then dislodged from the gut and expelled in feces. 1,4-Diazacyclohexane,1,4-Piperazine,Piperazine Diacetate,Piperazine Dihydrochloride,Piperazine Hexahydrate,Piperazine Hydrate,Piperazine Hydrobromide,Piperazine Hydrochloride,Piperazine Monohydrochloride,Piperazine Phosphate,Piperazine Phosphate (1:1),Piperazine Phosphate Anhydrous,Piperazine Salt,Piperazine Sulfate,Piperazine Tartrate,Piperazine Tartrate (1:1), (R-(R*,R*))-isomer,Piperazine Tartrate, (R-(R*,R*))-isomer,Piperazinium Oleate,Pripsen,1,4 Diazacyclohexane,1,4 Piperazine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
April 2022, ChemMedChem,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
July 2006, Bioorganic & medicinal chemistry letters,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
October 2018, Bioorganic & medicinal chemistry letters,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
May 2013, Journal of medicinal chemistry,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
January 2000, European journal of medicinal chemistry,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
May 2012, Bioorganic & medicinal chemistry letters,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
September 1995, Journal of medicinal chemistry,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
January 2017, Acta pharmacologica Sinica,
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
April 2009, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Masoud Sadeghzadeh, and Shahab Sheibani, and Mehdi Ghandi, and Fariba Johari Daha, and Massoud Amanlou, and Mohammad Arjmand, and Abolfazl Hasani Bozcheloie
March 2006, European journal of medicinal chemistry,
Copied contents to your clipboard!